Developer docs
API playgroundTry for free, no card

Search company profiles

Bio-Matrix Scientific Group

Full company profile

uuid003h2zg

Namestring
Bio-Matrix Scientific Group
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Bio-Matrix Scientific Group is referenced in the aggregated source material as an entity associated with the domain regenbiopharma.com, a domain name that suggests a focus on regenerative biopharmaceuticals. The associated URL appears to point to a corporate web presence, though no substantive operational, product, or corporate-structure information is documented in the available data.

The only source provided consists of a minimal webpage fragment that contains only a cookie notice link ("Do Not Sell or Share My Personal Information") and a tracking pixel URL — there is no descriptive copy, product information, leadership disclosure, investor information, or any other business-relevant content. All structured data fields accompanying this source — including revenue, headcount, founded date, company type, legal name, ownership, operating geographies, products and services, technology, management team, partnerships, and funding — are empty or explicitly marked as unavailable.

Consequently, the company's core product offering, underlying technology platform, business model, pricing mechanics, go-to-market motion, and target customer segments cannot be characterized from the available evidence. The company cannot be described as active, dormant, pre-launch, or otherwise without exceeding the bounds of the input data. Any further characterization would constitute speculation rather than grounded analysis.

Short descriptiontext

Bio-Matrix Scientific Group is associated with the domain regenbiopharma.com, suggesting a regenerative biopharmaceutical focus, but no substantive information about its products, customers, operations, or business model is available in the source data.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLa Mesa, United States
HQ citystring
La Mesa
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biopharmaceutical research, regenerative medicine, cell therapy development, tissue engineering, biotech scientific services
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biopharmaceutical Research
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Source data provides no substantive information about the company's products or services. The only available source is a minimal webpage fragment from regenbiopharma.com containing only a cookie notice link, with no description of any offerings. from the company name "Bio-Matrix Scientific Group" and the associated domain "regenbiopharma.com", the company may operate in the regenerative biopharmaceutical / biological matrix research space, but this is not confirmed by any first-party content in the input.

Differentiator
Functional benefit
Problem solved
No data
Market position
Customer concentration

Classification, Details

No data
Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bio-Matrix Scientific Group

Biopharmaceutical Researchregenbiopharma.com

Bio-Matrix Scientific Group is associated with the domain regenbiopharma.com, suggesting a regenerative biopharmaceutical focus, but no substantive information about its products, customers, operations, or business model is available in the source data.

What Bio-Matrix Scientific Group does

Bio-Matrix Scientific Group is referenced in the aggregated source material as an entity associated with the domain regenbiopharma.com, a domain name that suggests a focus on regenerative biopharmaceuticals. The associated URL appears to point to a corporate web presence, though no substantive operational, product, or corporate-structure information is documented in the available data.

The only source provided consists of a minimal webpage fragment that contains only a cookie notice link ("Do Not Sell or Share My Personal Information") and a tracking pixel URL — there is no descriptive copy, product information, leadership disclosure, investor information, or any other business-relevant content. All structured data fields accompanying this source — including revenue, headcount, founded date, company type, legal name, ownership, operating geographies, products and services, technology, management team, partnerships, and funding — are empty or explicitly marked as unavailable.

Consequently, the company's core product offering, underlying technology platform, business model, pricing mechanics, go-to-market motion, and target customer segments cannot be characterized from the available evidence. The company cannot be described as active, dormant, pre-launch, or otherwise without exceeding the bounds of the input data. Any further characterization would constitute speculation rather than grounded analysis.

Bio-Matrix Scientific Group firmographics

Firmographics
Name
Bio-Matrix Scientific Group
Website
https://regenbiopharma.com
Company type
Private
Founded year
1998
Headcount range
1–10 employees
Short description
Bio-Matrix Scientific Group is associated with the domain regenbiopharma.com, suggesting a regenerative biopharmaceutical focus, but no substantive information about its products, customers, operations, or business model is available in the source data.
Ownership category
akta.pro rank

Where Bio-Matrix Scientific Group is headquartered

Location

Headquarters

HQ city
La Mesa
HQ country
United States
HQ region
North America

Markets served

Bio-Matrix Scientific Group business model

Business model
GTM type
B2B
Offering type
Services

Bio-Matrix Scientific Group product offering

Product offering

Core offering

Source data provides no substantive information about the company's products or services. The only available source is a minimal webpage fragment from regenbiopharma.com containing only a cookie notice link, with no description of any offerings. from the company name "Bio-Matrix Scientific Group" and the associated domain "regenbiopharma.com", the company may operate in the regenerative biopharmaceutical / biological matrix research space, but this is not confirmed by any first-party content in the input.

Differentiator

Problem solved

Functional benefit

Bio-Matrix Scientific Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bio-Matrix Scientific Group competitors and assessment

Company assessment

Market position

Customer concentration

Bio-Matrix Scientific Group social profiles

Digital presence

Bio-Matrix Scientific Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bio-Matrix Scientific Group leadership team

Management profile

Number of profiles

Bio-Matrix Scientific Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bio-Matrix Scientific Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio-Matrix Scientific Group

What does Bio-Matrix Scientific Group do?

Source data provides no substantive information about the company's products or services. The only available source is a minimal webpage fragment from regenbiopharma.com containing only a cookie notice link, with no description of any offerings. from the company name "Bio-Matrix Scientific Group" and the associated domain "regenbiopharma.com", the company may operate in the regenerative biopharmaceutical / biological matrix research space, but this is not confirmed by any first-party content in the input.

When was Bio-Matrix Scientific Group founded?

Bio-Matrix Scientific Group was founded in 1998. It employs 1 to 10 people.

Where is Bio-Matrix Scientific Group based?

Bio-Matrix Scientific Group is headquartered in La Mesa, United States, in the North America region.

Does Bio-Matrix Scientific Group have an API?

No public API is recorded for Bio-Matrix Scientific Group.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireBio-Matrix Scientific Group in Discussions on Possible Stem Cell Repository VenturesBio-Matrix Scientific Group announced discussions with organizations to establish adult stem cell repositories at its 15,000 sq. ft. San Diego facility. The company sees potential in cancer stem cells, therapeutic storage, and tumor banking, with initiation possible in the near term.GlobeNewswireBio-Matrix Scientific Group Chairman Sees Future of Stem Cell Therapies Focused on Stem Cell RepositoriesBio-Matrix Scientific Group Chairman David Koos said stem cell therapies will increase demand for stem cell repositories, with bone marrow, endometrial, and adipose banking exceeding cord blood banking. The company is identifying partners to develop adult stem cell repositories in various locations.GlobeNewswireEntest CEO Blogcast Today at 10:00 am Covering Strategic Rollout of ImenVax(TM) -- an Immuno-Therapeutic Cancer Vaccine for DogsEntest BioMedical CEO David Koos will host a blogcast on September 21 at 10:00 am PDT, covering ImenVax's commercialization timeline, the veterinary therapy market, and plans to acquire veterinary clinics for revenue and distribution. The update also notes that shareholders of Bio-Matrix Scientific Group, Entest's majority owner, are encouraged to participate.GlobeNewswireCord Blood America Adds Third Stem Cell Practice, Enters Into Agreement With Bio-Matrix Scientific Group to Store Adipose Stem CellsCord Blood America announced an agreement with Bio-Matrix Scientific Group to market adipose stem cell storage services across the U.S., adding a third adult stem cell offering. The company now offers cord blood, adult peripheral stem cells, and adipose stem cells, with Bio-Matrix planning to build three research laboratories and a stem cell bank within three months.GlobeNewswireWall Street News Alert's Stocks on the Move! March 24, 2005Bio-Matrix Scientific Group appointed James L. Lambert as Bio-Instrument Scientific Advisor, a former JPL supervisor. The company's stock closed at 37 cents a share. Other stocks showed activity: Amgen up 1.1%, Intel up 1.6%, Yahoo down 0.3%.GlobeNewswireWall Street News Alert: U.S. Hot Stock Highlights, March 24, 2005Bio-Matrix Scientific Group appointed Dr. James L. Lambert as Bio-Instrument Scientific Advisor, a former JPL supervisor. The company's stock closed at 37 cents a share. Other stocks showed activity: Lucent down 1%, Applied Materials up 2.5%, Cisco down 0.9%.GlobeNewswireBrian Pockett, President of Bio-Matrix Scientific Group, Inc., Talks with Traders Nation About Stem Cell Banking, Reduction in Patient Trauma and Cash On HandTraders Nation announced an interview with Brian Pockett, president of Bio-Matrix Scientific Group, covering stem cell banking, tissue engineering, drug delivery, and cash on hand. The company is a biotechnology R&D firm developing intellectual properties. The interview is available on the Traders Nation website.